Mesa Laboratories (NASDAQ:MLAB) Director John James Sullivan Sells 7,093 Shares

Posted by Francis Steltz on Aug 18th, 2026

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) Director John James Sullivan sold 7,093 shares of the stock in a transaction that occurred on Thursday, August 13th. The shares were sold at an average price of $112.80, for a total transaction of $800,090.40. Following the sale, the director directly owned 17,834 shares in the company, valued at $2,011,675.20. This trade represents a 28.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Mesa Laboratories Stock Performance

MLAB stock opened at $107.64 on Tuesday. The company has a 50 day moving average price of $100.62 and a 200 day moving average price of $96.26. Mesa Laboratories, Inc. has a fifty-two week low of $58.83 and a fifty-two week high of $115.52. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.79 and a quick ratio of 1.32. The stock has a market capitalization of $602.78 million, a PE ratio of 128.14 and a beta of 0.92.

Mesa Laboratories (NASDAQ:MLAB – Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The medical instruments supplier reported $2.68 EPS for the quarter. The firm had revenue of $60.14 million for the quarter. Mesa Laboratories had a return on equity of 22.72% and a net margin of 1.92%.

Mesa Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Monday, August 31st will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, August 31st. Mesa Laboratories’s dividend payout ratio is 76.19%.

Analyst Upgrades and Downgrades

MLAB has been the subject of a number of research reports. Wall Street Zen lowered Mesa Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Wells Fargo & Company upped their target price on shares of Mesa Laboratories from $94.00 to $110.00 and gave the company an “equal weight” rating in a research report on Friday. Finally, Weiss Ratings upgraded shares of Mesa Laboratories from a “sell (d)” rating to a “hold (c-)” rating in a research report on Tuesday, August 11th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $110.00.

Read Our Latest Research Report on MLAB

Institutional Trading of Mesa Laboratories

A number of institutional investors have recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. boosted its holdings in Mesa Laboratories by 5,366.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 322 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in Mesa Laboratories during the 4th quarter worth about $27,000. Kestra Advisory Services LLC bought a new stake in Mesa Laboratories during the 4th quarter worth about $55,000. BNP Paribas Financial Markets grew its stake in Mesa Laboratories by 30.9% in the third quarter. BNP Paribas Financial Markets now owns 1,029 shares of the medical instruments supplier’s stock valued at $69,000 after purchasing an additional 243 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its holdings in shares of Mesa Laboratories by 432.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock valued at $79,000 after buying an additional 684 shares during the last quarter. 90.60% of the stock is currently owned by institutional investors.

Mesa Laboratories Company Profile

(Get Free Report)

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.